Vaxil Bio Ltd. (VXL.V)
0.16
0.00 (0.00%)
CAD |
TSXV |
Aug 27, 16:00
Vaxil Bio Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0112 |
| September 30, 2020 | 0.68 |
| June 30, 2020 | 0.4482 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5297 |
| December 31, 2019 | -0.2024 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.1126 |
| September 30, 2018 | 0.0305 |
| June 30, 2018 | 0.0444 |
| March 31, 2018 | 0.0506 |
| December 31, 2017 | -0.1602 |
| September 30, 2017 | |
| June 30, 2017 | 0.2743 |
| March 31, 2017 | 0.1298 |
| December 31, 2016 | 0.154 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kane Biotech, Inc. | -1.352 |
| Quest PharmaTech, Inc. | 0.0378 |
| BriaCell Therapeutics Corp. | 0.00 |
| Waverley Pharma, Inc. | -1.299 |
| Goldcoast Resource Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.224M |
| Total Liabilities (Quarterly) | 0.03M |
| Shareholders Equity (Quarterly) | 1.194M |
| Current Ratio | 17.97 |